In healthy adults, a calcium ascorbate blend matched plasma vitamin C from ascorbic acid; white cells held more.
Review · 13 trials; the review gives no single total · Single doses to 60 days · industry-funded
Calder et al., Nutrients, 2025
Terms and sources
- calcium ascorbate blend
- Ester-C: calcium ascorbate with small amounts of vitamin C breakdown products. 7 of the 13 trials tested it.
- matched plasma vitamin C
- At 1,000 mg once, the review reports no plasma differences from ascorbic acid; one trial found a higher peak.
- white cells held more
- White blood cells held more vitamin C 24 hours after 1,000 mg in 2 trials. The review does not report a third result. Dickerson 2024, below, found less in white cells at 500 mg and no difference at 250 mg.
- industry-funded
- Nestlé Health Science paid for the review and its publication fee. One author did contract research for The Bountiful Co.; another sat on a Nature's Bounty advisory council.
Study · Free full text · about 25 min to read
Our estimate at about 200 words a minute, from the PMC full text.
Study summary
A 2025 review gathered 13 trials of vitamin C forms other than plain ascorbic acid in healthy adults. Seven tested Ester-C, a calcium ascorbate blend with vitamin C breakdown products. At 1,000 mg taken once, plasma vitamin C did not differ from ascorbic acid. In 2 trials, white blood cells held more vitamin C 24 hours later. Three small trials of liposomal forms found higher plasma levels. The review did not combine results into one number. Funding: Nestlé Health Science.
Adults took calcium ascorbate or ascorbic acid once; plasma vitamin C matched, white cells held less at 500 mg.
Trial · 93 completed · Single dose, 32 hours · maker-funded
Dickerson et al., Nutrients, 2024
Also counted in Calder 2025
Terms and sources
- calcium ascorbate
- The paper calls it calcium ascorbate; the 2025 review lists it as Ester-C. Each person took both forms, one after the other.
- plasma vitamin C matched
- Total vitamin C in plasma, at 250 mg (46 people) and at 500 mg (47 people). Oxidized vitamin C rose more with calcium ascorbate at 500 mg.
- white cells held less
- Total vitamin C in lymphocytes was lower with calcium ascorbate at 24 and 32 hours; statistically significant. At 250 mg, nothing differed. The authors' discussion describes greater retention in lymphocytes with calcium ascorbate.
- maker-funded
- The Bountiful Co., which supplied both forms, paid for the study under a service contract. Its staff did not collect or analyze data.
Study · Free full text · about 30 min to read
Our estimate at about 200 words a minute, from the PMC full text.
Study summary
Researchers compared calcium ascorbate with ascorbic acid in healthy US adults aged 18–60. In two separate studies, 46 people took 250 mg and 47 took 500 mg. Each person took both forms once, one after the other. Blood was tested for 32 hours. Total vitamin C in plasma did not differ between forms at either dose. At 500 mg, lymphocytes held less total vitamin C with calcium ascorbate at 24 and 32 hours. This was statistically significant. Oxidized vitamin C in plasma rose more with calcium ascorbate. There was no dummy pill. Funding: The Bountiful Co., which also supplied the capsules.
Adults took 500 mg of liposomal or standard vitamin C once; peak blood vitamin C was 27% higher with liposomal.
Trial · 27 people · Single dose, 24 hours · maker-funded
Purpura et al., European Journal of Nutrition, 2024
Also counted in Calder 2025
Terms and sources
- liposomal
- LipoVantage by Specnova: ascorbic acid in sunflower lecithin liposomes.
- peak blood vitamin C
- Plasma. White blood cells: peak 20% higher. Total over 24 hours: plasma 21%, white cells 8% higher. All statistically significant.
- maker-funded
- Specnova, maker of LipoVantage, paid for the study. The authors declare no conflicts.
Study · Free full text · about 18 min to read
Our estimate at about 200 words a minute, from the PMC full text.
Study summary
Researchers compared liposomal vitamin C, standard vitamin C and a dummy pill. 27 healthy adults aged 18–45 in India took part. Each took all three once, 3 days apart, one after the other. Each dose had 500 mg of vitamin C. Peak plasma vitamin C was 27% higher with the liposomal form. Total plasma vitamin C over 24 hours was 21% higher. White blood cells showed smaller gains. These differences were statistically significant. Daily use was not tested. Funding: Specnova, maker of the liposomal form.
Young men had 50 mg daily from a tablet or half a kiwifruit; blood levels did not differ.
Trial · 36 people · 6 weeks · maker-funded
Carr et al., Nutrients, 2013
Terms and sources
- Young men
- Non-smokers aged 18–35 in New Zealand, with blood vitamin C below the screening average.
- half a kiwifruit
- Gold kiwifruit, about 53 mg of vitamin C; the tablet had 52 mg.
- blood levels did not differ
- Plasma rose from about 23 to about 46–51 µmol/L in the two groups. Urine, white cells and muscle did not differ either.
- maker-funded
- The paper names Zespri International, which supplied the kiwifruit, and the University of Otago as sources of backing. Tishcon Corp. supplied the tablets.
Study · Free full text · about 15 min to read
Our estimate at about 200 words a minute, from the PMC full text.
Study summary
Researchers compared vitamin C from a tablet and from fruit. 36 young non-smoking men in New Zealand took part for 6 weeks. Their blood vitamin C was below average at the start. Daily, 18 chewed a 50 mg tablet and 18 ate half a gold kiwifruit with the same amount. Plasma vitamin C rose from about 23 to about 46–51 µmol/L in the two groups. Urine, white blood cells and muscle did not differ either. There was no dummy group. Funding: backing from the University of Otago and Zespri International, which supplied the kiwifruit.
Young adults with low blood vitamin C drank 1,000 mg daily for 4 weeks; attention rose, tiredness did not differ.
Trial · 50 people · 4 weeks · maker-funded
Sim et al., European Journal of Nutrition, 2021
Terms and sources
- low blood vitamin C
- Below 50 µmol/L at the start; aged 20–39, without known illness, in Seoul.
- drank 1,000 mg daily
- 500 mg twice a day in a sweet 100 mL drink. A dummy drink was the same without vitamin C.
- attention rose
- Self-rated attention and work absorption rose more than with the dummy drink. These differences were statistically significant.
- tiredness did not differ
- Self-rated tiredness; the difference was not statistically significant. Mood scores did not differ.
- maker-funded
- Kwang Dong Pharmaceutical, which made the drinks, paid with the National Research Foundation of Korea. Two authors work at Kwang Dong.
Study · Free full text · about 25 min to read
Our estimate at about 200 words a minute, from the PMC full text.
Study summary
Researchers compared a vitamin C drink with a dummy drink in Korea. 50 adults aged 20–39 without known illness took part for 4 weeks. Their blood vitamin C was below 50 µmol/L at the start. One group drank 500 mg twice a day. Self-rated attention and work absorption rose more than with the dummy drink. These differences were statistically significant. Tiredness and mood scores did not differ. Funding: Kwang Dong Pharmaceutical, which made the drinks, and a Korean government research fund.
Men took 400 mg daily before and after downhill running; soreness and muscle damage markers did not differ.
Trial · 14 people · 17 days · funding not stated
Thompson et al., European Journal of Applied Physiology, 2004
Terms and sources
- 400 mg daily
- 200 mg of ascorbic acid twice a day, 14 days before and 3 days after.
- downhill running
- 30 minutes at a downhill gradient of 18%.
- muscle damage markers
- Creatine kinase and myoglobin in blood.
- funding not stated
- We could not find who paid for this study or supplied the product.
Study · Abstract only · about 1 min to read
Our estimate at about 200 words a minute, from the PubMed abstract.
Study summary
Researchers compared ascorbic acid with a dummy pill in 14 healthy UK men. One group took 200 mg twice a day for 14 days. Then all ran downhill for 30 minutes, and capsules continued for 3 days. Blood vitamin C rose in the vitamin C group. Muscle soreness and blood markers of muscle damage rose by similar amounts in both groups. Interleukin-6, a signal molecule, did not differ either. Funding: not named in the abstract; we could not open the full text.
Men took 400 mg daily for 2 weeks before hard running; soreness was modestly lower, damage markers did not differ.
Trial · 16 people · 2 weeks · funding not stated
Thompson et al., International Journal of Sport Nutrition and Exercise Metabolism, 2001
Terms and sources
- 400 mg daily
- 200 mg of ascorbic acid twice a day.
- hard running
- A 90-minute stop-and-go shuttle-running test.
- modestly lower
- The authors call the effects on soreness and muscle function modest. The abstract gives no test result for soreness.
- damage markers
- Creatine kinase and myoglobin in blood.
- funding not stated
- We could not find who paid for this study or supplied the product.
Study · Abstract only · about 1 min to read
Our estimate at about 200 words a minute, from the PubMed abstract.
Study summary
Researchers compared ascorbic acid with a dummy pill in 16 healthy UK men. Eight took 200 mg twice a day for 2 weeks; eight took the dummy pill. Then all did a 90-minute stop-and-go running test. Blood markers of muscle damage did not differ between groups. The authors report modest effects on soreness and muscle function. The abstract gives no test result for these. Interleukin-6 was lower 2 hours after running, a statistically significant difference. Funding: not named in the abstract.